Masimo | MASI - Cash And Equivalent



Masimo reported $149.6M in Cash and Equivalent for its fiscal quarter ending in June of 2025.


Cash And Equivalent Change Date
Abbott USD 6.95B 419M Jun/2025
Align Technology USD 873.01M 170.88M Mar/2025
AtriCure USD 117.8M 17.91M Jun/2025
Avanos Medical USD 90.3M 6.7M Jun/2025
Baxter International USD 2.29B 530M Mar/2025
Becton, Dickinson and Co. USD 735M 68M Jun/2025
Boston Scientific USD 725M 311M Mar/2025
Dexcom USD 1.16B 254.1M Jun/2025
Edwards Lifesciences USD 3.14B 95.4M Mar/2025
General Electric Aerospace USD 10.86B 1.54B Jun/2025
Globus Medical USD 229.45M 231.82M Jun/2025
Haemonetics USD 292.9M 13.86M Jun/2025
Insulet USD 1.12B 107M Jun/2025
Integra LifeSciences USD 217.91M 21.19M Jun/2025
Intuitive Surgical USD 9.53B 431.3M Jun/2025
Masimo USD 149.6M 18.8M Jun/2025
Medtronic USD 2.22B 978M Apr/2025
Owens Minor USD 59.44M 10.05M Mar/2025
ResMed USD 1.21B 276.74M Jun/2025
Steris USD 279.7M 108M Jun/2025
Stryker USD 2.38B 55M Jun/2025
Tandem Diabetes Care USD 64.11M 10.54M Jun/2025
Teleflex USD 253.7M 30.42M Jun/2025
Thermo Fisher Scientific USD 4.58B 442M Jun/2025
Zimmer Biomet Holdings USD 556.9M 827.6M Jun/2025